Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Your Observer

Hosptial joins clinical trial of new heart failure treatment

Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
Healio

Novel ICD platform may benefit patients with HFrEF at risk for sudden cardiac death

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
MedPage Today

Hybrid Device for Heart Failure Shows Early Promise

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Yahoo Finance

BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing

BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...
Business Wire

Cardialen Announces Positive Results from Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation

MINNEAPOLIS--(BUSINESS WIRE)--Cardialen, Inc., has published a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology titled Novel Low-Voltage MultiPulse ...